Application of DKK1 as diagnostic marker
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- SHANGHAI INST OF ONCOLOGY
- Publication Date
- 2014-01-01
- Estimated Expiration
- Not applicable · inactive patent
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
technical field
[0001] The present invention belongs to the field of biomedicine; more specifically, the present invention relates to the use of DKK1 as a diagnostic marker, which can be used for: diagnosing alpha-fetoprotein-negative hepatocellular carcinoma, differentiating hepatocellular carcinoma and alpha-fetoprotein-positive chronic liver disease and / or diagnosing Early-stage hepatocellular carcinoma or small hepatocellular carcinoma. Background technique
[0002] Primary liver tumors include hepatocellular carcinoma (HCC), intrahepatic cholangiocarcinoma, mixed hepatocellular carcinoma, cystadenoma of the bile duct, hepatoblastoma, hemangioma, carcinoid, lymphoma, epithelioid vascular endothelium Tumor, squamous cell carcinoma, teratoma, and leiomyosarcoma, fibrosarcoma, malignant fibrous histiocytoma, rhabdomyosarcoma and other liver sarcomas. Hepatocellular carcinoma (HCC) is one of the histological subtypes. Hepatocellular carcinoma (HCC) is one of the most commo...